{"id":"NCT01709500","sponsor":"Regeneron Pharmaceuticals","briefTitle":"Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2014-05","completion":"2015-01","firstPosted":"2012-10-18","resultsPosted":"2015-10-28","lastUpdate":"2015-10-28"},"enrollment":249,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heterozygous Familial Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"LMT (atorvastatin, simvastatin, or rosuvastatin)","otherNames":[]},{"type":"DRUG","name":"alirocumab","otherNames":["REGN727","SAR236553"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Alirocumab 75 mg/up to 150 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, parallel-group, multi-national study alirocumab (REGN727/SAR236553) in patients with Heterozygous Familial Hypercholesterolemia (heFH) who are not adequately controlled with their Lipid-Modifying Therapy (LMT).","primaryOutcome":{"measure":"Percent Change From Baseline in Calculated LDL-C at Week 24 - Intent--to--Treat (ITT) Analysis","timeFrame":"From Baseline to Week 52","effectByArm":[{"arm":"Alirocumab 75 mg/up to 150 mg","deltaMin":-48.7,"sd":1.9},{"arm":"Placebo","deltaMin":2.8,"sd":2.8}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":24,"countries":["Czechia","Netherlands","Norway","United Kingdom"]},"refs":{"pmids":["34298554","30183102","28964736","28391886","27777279","26330422","24842558"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":167},"commonTop":["Nasopharyngitis","Influenza","Injection site reaction","Headache","Myalgia"]}}